Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials

Opiate Suicide Study in Patients With Major Depression

To see complete record on, please visit this link

Id: NCT04116528

Organisation Name: Stanford University

Overal Status: Recruiting

Start Date: August 1, 2020

Last Update: November 3, 2022

Lead Sponsor: Stanford University

Brief Summary: To explore whether intravenous ketamine followed by buprenorphine produces more rapid and sustained anti-suicidal effects than ketamine followed by placebo, investigators will conduct a single study that will take approximately 2.5 years to complete. 60 subjects (60 infusions) or approximately 24 infusions per year.

  • Major Depressive Disorder

Total execution time in seconds: 0.30182790756226